Ecraid joins the #PrIMAVeRa_AMR Consortium to accelerate #AMR modelling!

This strategic partnership is a powerful step forward in the fight against #AntimicrobialResistance.

👉🏽Learn more about this vital collaboration & its impact on public health: www.ecraid.eu/news/ecraid-...

#StopSuperbugs

World AMR Awareness Week 2025 – Act Now: Protect Our Present, Secure Our Future. Vaccines play a vital, but sometimes underappreciated, role in the fight against AMR.

Vaccines are a powerful, preventive tool to tackle #AMR.
EVI is advancing 💉new Shigella & ETEC vaccines,💡data tools for policymakers & 🧬AI-driven diagnostics.

Together, we can #StopSuperbugs.
#WAAW2025 #ActNow

www.euvaccine.eu/post/world-a...

AMR: Fixing the broken pipeline for new antibiotics AMR is projected to cause ten million deaths a year by 2050. So, what are the barriers and solutions behind the creation of new antibiotics?

A recent article in Open Access Government by Melissa Gong Mitchell of the AMR Industry Alliance highlighted the urgent need to fix the broken antibiotic R&D pipeline and the role of push incentives like CARB-X in driving early-stage R&D.
🔗 Read more: bit.ly/43ZWj3e
#AMR #StopSuperbugs

Enhanced collaboration and a global approach are necessary to make further progress on AMR. CARB-X is committed to supporting researchers around the globe who are developing the next generation of antibacterial solutions to save lives.
#AMR #StopSuperbugs #Superbugs

CARB-X is pleased to see the first patient dosed in @sniprbiome.bsky.social’s Phase 1b clinical trial of SNIPR001, a trial co-funded by CARB-X. Read more about SNIPR001, a CRISPR-armed phage therapeutic that targets E.coli in the gut, and the trial below. 🧪
#AMR #StopSuperbugs #CRISPR #Phage

Global action on AMR. In Feb 2025, Uganda’s Harriet Akello met Till Bachmann @bachmanntill.bsky.social at the AMR Conf. in Switzerland merging frontline insights with global expertise. True progress needs local context and global collaboration. #AMR #GlobalHealth #OneHealth #StopSuperbugs

CARB-X Chief of R&D Erin Duffy introduced the funding themes for CARB-X's new funding round today at the 9th AMR Conference in Basel, Switzerland!

🔗 Learn more about the funding round, its themes, and timeframes to apply here: bit.ly/4k8Z5uC

🧪 #AMR #StopSuperbugs #DrugDevelopment

Join CARB-X team members Kevin Outterson, Erin Duffy, and Richard Alm at the 9th AMR Conference next week in Basel, Switzerland! #AMR #StopSuperbugs #AMRConference

👇 See the details of the panels below.
📆 February 25 – 26
🔗 Register here: bit.ly/41aMIXc

Bolstered by an internal R&D core team with decades of experience, the CARB-X Support Model connects experts with innovators, bridges science and knowhow, and creates an ecosystem where progress meets possibility to address the global threat of #AMR.
#StopSuperBugs #Biotechnology

Our newest output on #antibiotic use and access in poultry farming systems in Kenya

doi.org/10.1016/j.on...

@ilri.org
@livuni-ives.bsky.social
@wsuvetmed.bsky.social
etc al

#AMR
#StopSuperbugs
#OneHealth
Funded by the FlemingFund

👇 View the results from the 2024 CARB-X funding round. 

#AMR #StopSuperbugs #Biotechnology #ProductDevelopment #InfectiousDisease

What if a virus could reverse antibiotic resistance? In promising experiments, phage therapy forces bacteria into a no-win dilemma that lowers their defenses against drugs they’d evolved to withstand.

"#Phage therapy may have been too high-tech for the 1940s, and even today, scientists grapple with how to use it. What we need now are rigorous experiments that will teach us how to make it work."

#AMR #StopSuperbugs

www.asbmb.org/asbmb-today/...

Hello #Bluesky community!

I'm here to share and learn about #AMR, #StopSuperbugs, #access2meds, #GlobalHealth, #BizHumanRights, #HumanRights, and #ESG.

I really look forward to participating in fruitful and respectful conversations!

#NewJourney